Faeth Therapeutics, Inc. Depreciation and Amortization
Faeth Therapeutics, Inc. (FTH) reported Depreciation and Amortization of $54.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-04.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DepreciationDepletionAndAmortization · last filed 2026-08-04
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for the quarter ending 2026-06-30 was $25.00K, a 21.88% decline year-over-year.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for the quarter ending 2026-03-31 was $29.00K, a 3.33% decline year-over-year.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for the quarter ending 2025-12-31 was $30.00K, a 78.42% decline year-over-year.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for the quarter ending 2025-09-30 was $30.00K, a 78.57% decline year-over-year.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2025 was $122.00K, a 77.86% decline from fiscal 2024.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2024 was $551.00K, a 3.50% decline from fiscal 2023.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2023 was $571.00K, a 7.00% decline from fiscal 2022.
- Faeth Therapeutics, Inc. depreciation, depletion and amortization for fiscal 2022 was $614.00K, a 10.36% decline from fiscal 2021.
| Period end | Depreciation, Depletion and Amortization 3 month | Depreciation, Depletion and Amortization 6 month | Depreciation, Depletion and Amortization 9 month | Depreciation, Depletion and Amortization 12 month |
|---|---|---|---|---|
| 2026-06-30 | $25.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $54.00K 10-Q · filed 2026-08-04 | $84.00K derived: sum of 3 quarters · filed 2026-08-04 | $114.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2026-03-31 | $29.00K 10-Q · filed 2026-05-15 | $59.00K derived: sum of 2 quarters · filed 2026-05-15 | $89.00K derived: sum of 3 quarters · filed 2026-05-15 | $121.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-12-31 | $30.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $60.00K derived: sum of 2 quarters · filed 2026-03-30 | $92.00K derived: sum of 3 quarters · filed 2026-08-04 | $122.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $30.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-14 | $62.00K derived: sum of 2 quarters · filed 2026-08-04 | $92.00K 10-Q · filed 2025-11-14 | $231.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-06-30 | $32.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-04 | $62.00K 10-Q · filed 2026-08-04 | $201.00K derived: sum of 3 quarters · filed 2026-08-04 | $341.00K derived: sum of 4 quarters · filed 2026-08-04 |
| 2025-03-31 | $30.00K 10-Q · filed 2026-05-15 | $169.00K derived: sum of 2 quarters · filed 2026-05-15 | $309.00K derived: sum of 3 quarters · filed 2026-05-15 | $444.00K derived: sum of 4 quarters · filed 2026-05-15 |
| 2024-12-31 | $139.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | $279.00K derived: sum of 2 quarters · filed 2026-03-30 | $414.00K derived: sum of 3 quarters · filed 2026-03-30 | $551.00K 10-K · filed 2026-03-30 |
| 2024-09-30 | $140.00K 10-Q · filed 2024-11-14 | $275.00K derived: sum of 2 quarters · filed 2024-11-14 | $412.00K 10-Q · filed 2025-11-14 | $547.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-06-30 | $135.00K 10-Q · filed 2024-08-06 | $272.00K 10-Q · filed 2025-08-05 | $407.00K derived: sum of 3 quarters · filed 2025-05-06 | $544.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2024-03-31 | $137.00K 10-Q · filed 2025-05-06 | $272.00K derived: sum of 2 quarters · filed 2025-05-06 | $409.00K derived: sum of 3 quarters · filed 2025-05-06 | $547.00K derived: sum of 4 quarters · filed 2025-05-06 |
| 2023-12-31 | $135.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-28 | $272.00K derived: sum of 2 quarters · filed 2025-03-28 | $410.00K derived: sum of 3 quarters · filed 2025-03-28 | $571.00K 10-K · filed 2025-03-28 |
| 2023-09-30 | $137.00K 10-Q · filed 2024-11-14 | $275.00K derived: sum of 2 quarters · filed 2024-11-14 | $436.00K 10-Q · filed 2024-11-14 | $598.00K derived: sum of 4 quarters · filed 2024-11-14 |
| 2023-06-30 | $138.00K 10-Q · filed 2024-08-06 | $299.00K 10-Q · filed 2024-08-06 | $461.00K derived: sum of 3 quarters · filed 2024-08-06 | $612.00K derived: sum of 4 quarters · filed 2024-08-06 |
| 2023-03-31 | $161.00K 10-Q · filed 2024-05-09 | $323.00K derived: sum of 2 quarters · filed 2024-05-09 | $474.00K derived: sum of 3 quarters · filed 2024-05-09 | $618.00K derived: sum of 4 quarters · filed 2024-05-09 |
| 2022-12-31 | $162.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $313.00K derived: sum of 2 quarters · filed 2024-02-29 | $457.00K derived: sum of 3 quarters · filed 2024-02-29 | $614.00K 10-K · filed 2024-02-29 |
| 2022-09-30 | $151.00K 10-Q · filed 2023-11-07 | $295.00K derived: sum of 2 quarters · filed 2023-11-07 | $452.00K 10-Q · filed 2023-11-07 | $781.00K derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $144.00K 10-Q · filed 2023-08-03 | $301.00K 10-Q · filed 2023-08-03 | $630.00K derived: sum of 3 quarters · filed 2023-08-03 | $766.00K derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $157.00K 10-Q · filed 2023-05-09 | $486.00K derived: sum of 2 quarters · filed 2023-05-09 | $622.00K derived: sum of 3 quarters · filed 2023-05-09 | $744.00K derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $329.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $465.00K derived: sum of 2 quarters · filed 2023-03-29 | $587.00K derived: sum of 3 quarters · filed 2023-03-29 | $685.00K 10-K · filed 2023-03-29 |
| 2021-09-30 | $136.00K 10-Q · filed 2022-11-08 | $258.00K derived: sum of 2 quarters · filed 2022-11-08 | $356.00K 10-Q · filed 2022-11-08 | $426.00K derived: sum of 4 quarters · filed 2022-11-08 |
| 2021-06-30 | $122.00K 10-Q · filed 2022-08-09 | $220.00K 10-Q · filed 2022-08-09 | $290.00K derived: sum of 3 quarters · filed 2022-08-09 | $354.00K derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $98.00K 10-Q · filed 2022-05-10 | $168.00K derived: sum of 2 quarters · filed 2022-05-10 | $232.00K derived: sum of 3 quarters · filed 2022-05-10 | $284.00K derived: sum of 4 quarters · filed 2022-05-10 |
| 2020-12-31 | $70.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15 | $134.00K derived: sum of 2 quarters · filed 2022-03-15 | $186.00K derived: sum of 3 quarters · filed 2022-03-15 | $209.00K 10-K · filed 2022-03-15 |
| 2020-09-30 | $64.00K 10-Q · filed 2021-11-10 | $116.00K derived: sum of 2 quarters · filed 2021-11-10 | $139.00K 10-Q · filed 2021-11-10 | |
| 2020-06-30 | $52.00K 10-Q · filed 2021-08-11 | $75.00K 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $23.00K 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| Wave Life Sciences, Inc. (WVE) | $0.780B | -5.56 | |
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Verastem, Inc. (VSTM) | United States | $0.706B | -1.71 |
| Nuvectis Pharma, Inc. (NVCT) | United States | $0.705B | -17.53 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| IRONWOOD PHARMACEUTICALS INC (IRWD) | United States | $0.694B | 5.37 |
| Climb Bio, Inc. (CLYM) | United States | $0.683B | -13.03 |